Working to Overcome Health Disparities in AML
New research has uncovered gaps in AML care among certain groups of people. In this event, AML expert Dr. Hantel from the Dana-Farber Cancer Institute, will share what he's learned about disparities among people with AML. He will also provide his thoughts on how we can work toward ensuring that all patients with AML, regardless of race, income level, educational status and geographical location, receive the highest quality of care possible. Come with your questions and comments!
Katie Braswell
Katie joined the HealthTree Foundation as the Community Director for AML in 2021. She is a registered dietitian who previously worked at the VA hospital in Dallas, Texas where she coached veterans with blood cancer on how to use nutrition to improve their treatment outcomes and minimize cancer-related side effects. Katie is passionate about health education and patient empowerment. In her spare time, she loves to experiment with new recipes in the kitchen, spend time running outdoors, and travel to new places.
Andrew Hantel, MD
Dr. Hantel is a is a hospitalist in Medical Oncology and is a postdoctoral fellow in the Division of Population Science at Dana-Farber Cancer Institute. Dr. Hantel’s research focuses on investigating and advancing ethical issues of scarce resource allocation in hematology/oncology through patient-centered health services research methods. His research seeks to incorporate patient and physician perspectives into topical ethical dilemmas, thereby informing practice and policy. Dr. Hantel recently published a research paper titled "Racial and ethnic enrollment disparities and demographic reporting requirements in acute leukemia clinical trials."